Enter the first few characters of Company and click 'Go'
Audited Results of Suven Pharmaceuticals Ltd. Company
(Rs in Cr.) |
Mar 31, 2023 |
Mar 31, 2022 |
Mar 31, 2021 |
Mar 31, 2020 |
Mar 31, 2019 |
Operating Income |
1,330.08 |
1,320.22 |
1,009.72 |
833.79 |
377.83 |
Manufacturing Expenses |
168.93 |
170.74 |
120.98 |
104.80 |
50.77 |
Personnel Expenses |
100.84 |
100.48 |
87.29 |
73.72 |
29.63 |
Selling Expenses |
0 |
0 |
0 |
0 |
0 |
Administrative Expenses |
74.87 |
67.46 |
57.23 |
39.98 |
22.15 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Cost Of Sales |
747 |
740.23 |
569.20 |
448.64 |
206.28 |
Operating Profit |
583.08 |
579.99 |
440.52 |
385.15 |
171.55 |
Other Recurring Income |
44.55 |
187.79 |
14.24 |
18.12 |
0.60 |
Adjusted PBDIT |
627.63 |
767.78 |
454.76 |
403.26 |
172.15 |
Financial Expenses |
5.39 |
6.23 |
9.14 |
21.81 |
2.79 |
Depreciation |
42.84 |
39.10 |
31.64 |
23.86 |
11.50 |
Other Write offs |
0 |
0 |
0 |
0 |
0 |
Adjusted PBT |
579.39 |
722.45 |
413.98 |
357.59 |
157.87 |
Tax Charges |
146.79 |
164.35 |
105.33 |
87.51 |
48.59 |
Adjusted PAT |
432.60 |
558.10 |
308.65 |
270.08 |
109.27 |
Non Recurring Items |
-0.35 |
-0.76 |
0 |
-0.82 |
0 |
Other Non Cash adjustments |
0 |
0 |
0 |
0 |
0 |
Reported Net Profit |
432.60 |
558.10 |
308.65 |
270.08 |
109.27 |
Equity Dividend |
203.65 |
101.83 |
25.46 |
50.56 |
15.17 |
Preference Dividend |
0 |
0 |
0 |
0 |
0 |
Retained Earnings |
1,504.98 |
1,291.39 |
851.71 |
596.60 |
409.91 |